Ballast Point Ventures
Founded in 2002, Ballast Point prefers minority ownership stakes to control positions in companies throughout Florida, the Southeast and Texas. Based in St. Petersburg, Fla., the firm prefers to make more substantial investments from a dollars perspective in several industries, including healthcare. Companies in Ballast Point’s healthcare portfolio include TissueTech, a medical device company providing regenerative amniotic tissue-based products for use in the vision care, musculoskeletal and wound care markets; YPrime, a provider of software products and consulting services for global clinical trials; SleepMed, a medical products and services company focused on diagnosis and treatment in the sleep-disordered breathing market; and MolecularMD, a provider of molecular diagnostic tests supporting regulatory approval and clinical adoption of targeted cancer treatments.
